Estrella Immunopharma, Inc. (ESLA): debt financing — TradeUP Acquisition Corp. issues $60K promissory note to founder for working capital

Estrella Immunopharma, Inc.

Issued $60,000 unsecured promissory note to Tradeup INC., a founder, on June 6, 2023.
Note bears no interest; principal due upon business combination or company term expiry.
Payee may convert note into private shares at $10.00 per share at least two days before close.
Proceeds used for general working capital until initial business combination.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Estrella Immunopharma, Inc. incurred loan of $60,000 with Tradeup INC. at no interest maturing upon the earlier to occur of (i) the consummation of the Business Combination or (ii) the date of expiry of the term of the Company.

Instrument: loan
Principal: $60,000
Counterparty: Tradeup INC.
Rate: no interest
Maturity: upon the earlier to occur of (i) the consummation of the Business Combination or (ii) the date of expiry of the term of the Company
Event: incurrence

Exact text from the filing

On June 6, 2023, TradeUP Acquisition Corp. (the “Company”) issued an unsecured promissory note (the “Promissory Note”) in the amount of $60,000 to Tradeup INC., one of the founders of the Company.

View on SEC.gov

Browse all debt financings →

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001575872-23-000920

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.